181 related articles for article (PubMed ID: 7831033)
1. Lens-sparing vitrectomy with perfluorocarbon liquid for the primary treatment of giant retinal tears.
Verstraeten T; Williams GA; Chang S; Cox MS; Trese MT; Moussa M; Friberg TR
Ophthalmology; 1995 Jan; 102(1):17-20. PubMed ID: 7831033
[TBL] [Abstract][Full Text] [Related]
2. Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal tears.
Sirimaharaj M; Balachandran C; Chan WC; Hunyor AP; Chang AA; Gregory-Roberts J; Hunyor AB; Playfair TJ
Br J Ophthalmol; 2005 Sep; 89(9):1176-9. PubMed ID: 16113376
[TBL] [Abstract][Full Text] [Related]
3. The use of perfluoro-octane in the management of giant retinal tears without proliferative vitreoretinopathy.
Ie D; Glaser BM; Sjaarda RN; Thompson JT; Steinberg LE; Gordon LW
Retina; 1994; 14(4):323-8. PubMed ID: 7817025
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane.
Scott IU; Murray TG; Flynn HW; Feuer WJ; Schiffman JC;
Ophthalmology; 2002 Oct; 109(10):1828-33. PubMed ID: 12359602
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
Scott IU; Flynn HW; Murray TG; Feuer WJ;
Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors associated with outcomes after giant retinal tear management using perfluorocarbon liquids.
Al-Khairi AM; Al-Kahtani E; Kangave D; Abu El-Asrar AM
Eur J Ophthalmol; 2008; 18(2):270-7. PubMed ID: 18320521
[TBL] [Abstract][Full Text] [Related]
7. Management of giant retinal tears without scleral buckling. Use of radical dissection of the vitreous base and perfluoro-octane and intraocular tamponade.
Kreiger AE; Lewis H
Ophthalmology; 1992 Apr; 99(4):491-7. PubMed ID: 1584565
[TBL] [Abstract][Full Text] [Related]
8. [Retinal detachment associated with giant retinal tear: surgical procedures and results of the perfluorocarbon liquid-silicone oil exchange with scleral buckling].
Zhioua R; Malek I; Kria L; Ouertani A
J Fr Ophtalmol; 2005 Apr; 28(4):366-70. PubMed ID: 15973196
[TBL] [Abstract][Full Text] [Related]
9. Vitrectomy with silicone oil tamponade for retinal detachment associated with giant retinal tears: Favourable outcomes without adjuvant scleral buckling.
Hocaoglu M; Karacorlu M; Ersoz MG; Sayman Muslubas I; Arf S
Acta Ophthalmol; 2019 Mar; 97(2):e271-e276. PubMed ID: 30284388
[TBL] [Abstract][Full Text] [Related]
10. Results of 12-year clinical study of giant retinal tear.
Chen CH; Tsai MH; Su CC; Kou HK; Kao ML; Tsai SH; Chen YJ
Chang Gung Med J; 2001 Oct; 24(10):633-9. PubMed ID: 11771186
[TBL] [Abstract][Full Text] [Related]
11. [Giant retinal tears treated with lens sparing, bimanual 23 g vitrectomy without scleral buckle].
Quezada-Ruiz C; Cano-Hidalgo RA
Cir Cir; 2014; 82(3):245-51. PubMed ID: 25238465
[TBL] [Abstract][Full Text] [Related]
12. [Perfluoroctane liquid as a short-term vitreous-retinal tamponade in the postoperative period in patients with retinal detachment due to giant tears].
Ventura MC; Melo C; Escarião P; Diniz JR; Leão AC
Arq Bras Oftalmol; 2007; 70(3):495-500. PubMed ID: 17768558
[TBL] [Abstract][Full Text] [Related]
13. Short-Term Vitreoretinal Tamponade with Heavy Liquid Following Surgery for Giant Retinal Tear.
Eiger-Moscovich M; Gershoni A; Axer-Siegel R; Weinberger D; Ehrlich R
Curr Eye Res; 2017 Jul; 42(7):1074-1078. PubMed ID: 28157410
[TBL] [Abstract][Full Text] [Related]
14. The management of giant retinal tears using perfluoroperhydrophenanthrene. A multicenter case series. Vitreon Collaborative Study Group.
Kertes PJ; Wafapoor H; Peyman GA; Calixto N; Thompson H
Ophthalmology; 1997 Jul; 104(7):1159-65. PubMed ID: 9224470
[TBL] [Abstract][Full Text] [Related]
15. Management of giant retinal tears with vitrectomy, internal tamponade, and peripheral 360 degrees retinal photocoagulation.
Ambresin A; Wolfensberger TJ; Bovey EH
Retina; 2003 Oct; 23(5):622-8. PubMed ID: 14574245
[TBL] [Abstract][Full Text] [Related]
16. Combined cataract surgery and vitrectomy for recurrent retinal detachment.
Chaudhry NA; Flynn HW; Murray TG; Belfort A; Mello M
Retina; 2000; 20(3):257-61. PubMed ID: 10872930
[TBL] [Abstract][Full Text] [Related]
17. Anatomic and visual outcomes of 23-G vitrectomy without scleral buckling for primary rhegmatogenous retinal detachment.
Figueroa MS; Contreras I; Noval S;
Eur J Ophthalmol; 2013; 23(3):417-22. PubMed ID: 23483490
[TBL] [Abstract][Full Text] [Related]
18. Successful surgical outcomes after 23-, 25- and 27-gauge vitrectomy without scleral encircling for giant retinal tear.
Kunikata H; Aizawa N; Sato R; Nishiguchi KM; Abe T; Nakazawa T
Jpn J Ophthalmol; 2020 Sep; 64(5):506-515. PubMed ID: 32686061
[TBL] [Abstract][Full Text] [Related]
19. Primary vitrectomy versus conventional retinal detachment surgery in phakic rhegmatogenous retinal detachment.
Azad RV; Chanana B; Sharma YR; Vohra R
Acta Ophthalmol Scand; 2007 Aug; 85(5):540-5. PubMed ID: 17355251
[TBL] [Abstract][Full Text] [Related]
20. Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy.
Glaser BM; Carter JB; Kuppermann BD; Michels RG
Ophthalmology; 1991 Nov; 98(11):1613-21. PubMed ID: 1800921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
